Year |
Citation |
Score |
2017 |
Lorig-Roach N, Still PC, Coppage D, Compton JE, Crews MS, Navarro G, Tenney K, Crews P. Evaluating Nitrogen-Containing Biosynthetic Products Produced by Saltwater Culturing of Several California Littoral Zone Gram-Negative Bacteria. Journal of Natural Products. PMID 28777571 DOI: 10.1021/Acs.Jnatprod.7B00302 |
0.575 |
|
2015 |
Theodore CM, Lorig-Roach N, Still PC, Johnson TA, Draškovi? M, Schwochert JA, Naphen CN, Crews MS, Barker SA, Valeriote FA, Lokey RS, Crews P. Biosynthetic products from a nearshore-derived gram-negative bacterium enable reassessment of the kailuin depsipeptides. Journal of Natural Products. 78: 441-52. PMID 25699470 DOI: 10.1021/Np500840N |
0.588 |
|
2014 |
Pérez LB, Still PC, Naman CB, Ren Y, Pan L, Chai HB, Carcache de Blanco EJ, Ninh TN, Van Thanh B, Swanson SM, Soejarto DD, Kinghorn AD. Investigation of Vietnamese plants for potential anticancer agents. Phytochemistry Reviews : Proceedings of the Phytochemical Society of Europe. 13: 727-739. PMID 25395897 DOI: 10.1007/S11101-014-9335-7 |
0.508 |
|
2014 |
Still PC, Johnson TA, Theodore CM, Loveridge ST, Crews P. Scrutinizing the scaffolds of marine biosynthetics from different source organisms: Gram-negative cultured bacterial products enter center stage. Journal of Natural Products. 77: 690-702. PMID 24571234 DOI: 10.1021/Np500041X |
0.581 |
|
2013 |
Still PC, Yi B, González-Cestari TF, Pan L, Pavlovicz RE, Chai HB, Ninh TN, Li C, Soejarto DD, McKay DB, Kinghorn AD. Alkaloids from Microcos paniculata with cytotoxic and nicotinic receptor antagonistic activities. Journal of Natural Products. 76: 243-9. PMID 23327794 DOI: 10.1021/Np3007414 |
0.517 |
|
2012 |
Ren Y, Wei M, Still PC, Yuan S, Deng Y, Chen X, Himmeldirk K, Kinghorn AD, Yu J. Synthesis and Antitumor Activity of Ellagic Acid Peracetate. Acs Medicinal Chemistry Letters. 3: 631-636. PMID 23185648 DOI: 10.1021/Ml300065Z |
0.46 |
|
2010 |
Lucas DM, Still PC, Pérez LB, Grever MR, Kinghorn AD. Potential of plant-derived natural products in the treatment of leukemia and lymphoma. Current Drug Targets. 11: 812-22. PMID 20370646 DOI: 10.2174/138945010791320809 |
0.531 |
|
Show low-probability matches. |